Genuone is a leading pharmaceutical CDMO (Contract Development Manufacturing Organization) in South Korea capable of providing a wide coverage of drug dosage forms including oral solid, capsules, liquids, injections, and ointments
Genuone is well poised to benefit from the growing local and global pharmaceutical outsourcing demand based on its longstanding track record of operation excellence
Genuone is well poised to benefit from the growing local and global pharmaceutical outsourcing demand based on its longstanding track record of operation excellence
Investors 1
| Date | Name | Website |
| - | IMM Privat... | immholding... |
Mentions in press and media 1
| Date | Title | Description |
| 05.08.2024 | Macquarie buys Korean drug company Genuone Sciences in $550m deal | Macquarie Asset Management’s private equity fund is understood to have sealed the deal to acquire a 100% stake in Korean contract development and manufacturing organisation (CDMO) Genuone Sciences from local investor IMM Private Equity, acc... |